Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | BPH GLOBAL LTD: Consolidation/Split - BP8 | - | ASX | ||
Mo | BPH GLOBAL LTD: EGM Letter of Access | - | ASX | ||
Mo | BPH GLOBAL LTD: Notice of Extraordinary General Meeting/Proxy Form | - | ASX | ||
12.04. | BPH GLOBAL LTD: Initial Trading Results to be included in Appendix 4C Report | - | ASX | ||
11.04. | BPH GLOBAL LTD: Company Secretary Appointment & Change of Registered Office | - | ASX | ||
18.03. | BPH GLOBAL LTD: 120-Day Business Development Plan | - | ASX | ||
12.03. | BPH GLOBAL LTD: AI tech to expand seaweed R&D into battery industries | - | ASX | ||
27.02. | BPH GLOBAL LTD: Half Yearly Report and Accounts | - | ASX | ||
09.02. | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | - | ASX | ||
09.02. | BPH GLOBAL LTD: Application for quotation of securities - BP8 | - | ASX | ||
04.02. | BPH GLOBAL LTD: Renewal of China Tobacco Agreements | - | ASX | ||
31.01. | BPH GLOBAL LTD: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
18.01. | BPH GLOBAL LTD: Change of Joint Company Secretary | 1 | ASX | ||
15.12.23 | BPH GLOBAL LTD: Change of Director's Interest Notice | 1 | ASX | ||
15.12.23 | BPH GLOBAL LTD: Change of Director's Interest Notice | 1 | ASX | ||
15.12.23 | BPH GLOBAL LTD: Change of Director's Interest Notice | 1 | ASX | ||
13.12.23 | BPH GLOBAL LTD: Sale of platform in East Johor Strait | - | ASX | ||
10.12.23 | BPH GLOBAL LTD: Completion of acquisition of Foshan Gedishi Biotechnology Co | - | ASX | ||
08.12.23 | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | 1 | ASX | ||
08.12.23 | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | 1 | ASX |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIRONA BIOCHEM | 0,047 | +4,49 % | Sirona Biochem Corp.: SIRONA BIOCHEM Corporate Update April 2024 | VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) ("Sirona" or the "Company") provides the following update: Dear shareholders... ► Artikel lesen | |
REPLENISH NUTRIENTS | 0,050 | +7,76 % | Replenish Nutrients Holding Corp: Replenish Nutrients partners with Dark Horse | ||
AYALA PHARMACEUTICALS | 0,480 | -4,00 % | Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome | MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the completion of the previously announced... ► Artikel lesen | |
NEOVACS | 0,266 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 16.11.2023 | The following instruments on Boerse Frankfurt do have their last trading day on 16.11.2023.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 16.11.2023.ISIN NameAU000000SAU3 SOUTHERN... ► Artikel lesen | |
NANOSPHERE HEALTH SCIENCES | 0,019 | +111,11 % | The Morning After: 'Nanosphere' paint could reduce a plane's CO2 emissions | ||
GENETIC TECHNOLOGIES | 0,064 | 0,00 % | GENETIC TECHNOLOGIES LIMITED: Change in substantial holding | ||
TRIVARX | - | - | TRIVARX LTD: Cleansing Notice | ||
EQUATORIAL RESOURCES | 0,079 | 0,00 % | EQUATORIAL RESOURCES LIMITED: March 2024 Quarterly Report | ||
RECCE PHARMACEUTICALS | 0,440 | +2,33 % | ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential | ||
PYC THERAPEUTICS | - | - | PYC THERAPEUTICS LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | ||
PATRYS | 0,004 | 0,00 % | ASX Health Stocks: Patrys and Next Science jump after presenting data on studies | ||
EVOTEC | 9,235 | +0,82 % | Evotec, HelloFresh, K+S, Lanxess, Varta, Zalando und Co. - Aktien-Positionen der Shortseller | Wer Aktien leer verkauft, das sogenannte Shortselling, muss Transparenzpflichten erfüllen. Wir werfen einen Blick auf aktuelle Shortseller-Meldungen. Geregelt sind diese in der EU-Leerverkaufsverordnung... ► Artikel lesen | |
QIAGEN | 38,760 | +2,16 % | QIAGEN N.V.: QIAGEN erweitert Tuberkulose-Portfolio: Neues NGS-Panel unterstützt Echtzeit-Überwachung und Bekämpfung antimikrobieller Resistenzen | QIAseq xHYB Mycobacterium tuberculosis Panel zu Forschungszwecken ermöglicht kulturfreies Whole Genome Sequencing komplexer Proben // Panel beschleunigt Nachverfolgung von TB-Ausbrüchen und unterstützt... ► Artikel lesen | |
CULLINAN THERAPEUTICS | 25,140 | +30,60 % | PEGY, CGEM and IFBD among mid-day movers | ||
BIONTECH | 82,40 | +2,11 % | Neue 10,00% Aktienanleihe mit Barriere Quanto auf BioNTech in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VD3J8Q1/ WKN VD3J8Q) mit Barriere Quanto auf die Aktie von BioNTech... ► Artikel lesen |